MedPath

Bright Cell, Inc.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

Safety and Efficacy of YB-1113 in Treatment of POI

Phase 1
Not yet recruiting
Conditions
POI
Interventions
First Posted Date
2022-08-10
Last Posted Date
2025-02-13
Lead Sponsor
Bright Cell, Inc.
Target Recruit Count
6
Registration Number
NCT05494723

BC-101 in Treatment of Nasolabial Fold Wrinkles

Phase 1
Not yet recruiting
Conditions
Nasolabial Fold Wrinkles
Interventions
First Posted Date
2021-12-17
Last Posted Date
2025-02-12
Lead Sponsor
Bright Cell, Inc.
Target Recruit Count
9
Registration Number
NCT05162326
© Copyright 2025. All Rights Reserved by MedPath